clinical ivig 
European Pharmaceutical Review
JUNE 23, 2023
Study data from a major trial has demonstrated RNA CAR-T (rCAR-T) therapy Descartes-08 facilitated significant and long-lasting clinical improvement in generalised myasthenia gravis (gMG). This is the first clinical trial using rCAR-T to treat autoimmunity.
Pharmacy Times
SEPTEMBER 13, 2022
Asceniv is a plasma-derived polyclonal IVIG drug product designed to prevent serious bacterial infections in patients with primary humoral immunodeficiency disease.
Pharmaceutical Technology
JUNE 20, 2023
It involves an IVIg dependency and monitoring period, with two cohorts being dosed over 16 weeks. ARDA (NCT05225675) is a randomised, double-blind, placebo-controlled, multicentre study evaluating the effects of two dose regimens of ARGX-117 in MMN-diagnosed adults. MMN is a rare, progressive muscle disorder primarily affecting men.
Expert insights. Personalized for you.
98 
Let's personalize your content